Fourth quarter 2025 revenue increased 5% year-over-year to $4.2 million. Full year 2025 revenue grew 17% year-over-year to $16.6 million. Net loss for Q4 2025 was $16.0 million, an improvement from $21.7 million in Q4 2024. Full year 2025 net loss was $73.6 million, an improvement from $86.6 million in full year 2024. Installed instrument base expanded to 82, representing 67% year-over-year growth, with 33 instruments installed in 2025. Ended 2025 with approximately $240.6 million in cash, cash equivalents, and investments. Operating expenses decreased by 23% in Q4 2025 and 19% for the full year 2025, primarily due to reductions in stock-based compensation, professional services, and laboratory expenses.